Conference Coverage

In MS, iron-ringed lesions may add to imaging toolkit


 

REPORTING FROM ECTRIMS 2019

The presence of an iron ring around a brain lesion suspicious for multiple sclerosis (MS) may provide a promising adjunct to evolving magnetic resonance imaging techniques to track disease activity and progression, according to research presented at the annual congress of the European Committee for Treatment and Research in Multiple Sclerosis.

Dr. Margareta Clarke, a research fellow at the Vall d'Hebron Research Institute in Barcelona. Kari Oakes/MDedge News

Dr. Margareta Clarke

Using a conventional 3 Tesla magnetic resonance imaging (MRI) scanner, Margareta Clarke, PhD, and colleagues were able to identify iron rings (also called iron rims) and the central vein sign, and saw that both lesion characteristics were more common in MS patients than in those without MS.

“Routine two-dimensional 3 Tesla MRI with susceptibility weighting can be used to successfully visualize central veins and iron rims,” said Dr. Clarke, speaking at an imaging-focused young investigators’ session at the meeting. “Also, the central vein sign findings from previous 3T studies are confirmed.”

Dr. Clarke, a research fellow at the Vall d’Hebron Research Institute in Barcelona, explained that iron is stored within oligodendrocytes and myelin within the brain. In up to 56% of MS lesions, a rim of iron is visible with susceptibility weighted MRI imaging, she said, adding that the iron rings around the lesions “are likely caused by iron-laden activated microglia and macrophages that accumulate on the edges of lesions.”

It had been known that when lesions are surrounded by iron rings, they are more likely to enlarge and become increasingly hypointense on T1 weighted MRI. In addition, patients with more disability are more likely to have iron-rimmed brain lesions, said Dr. Clarke, and iron rings are associated with chronic disease activity. “Iron rings are a proposed marker of continuing inflammation and tissue loss,” she added.

Pages

Recommended Reading

Serum neurofilament light chain level may indicate MS disease activity
ICYMI Multiple Sclerosis
Pediatric-Onset MS May Slow Information Processing in Adulthood
ICYMI Multiple Sclerosis
Patients With MS Who Consider Marijuana Use More Likely to Engage in Risky Behaviors
ICYMI Multiple Sclerosis
Switching From Interferon Beta-1a to Alemtuzumab Improves MS Outcomes
ICYMI Multiple Sclerosis
Interview with Andrew Solomon, MD, on diagnosing multiple sclerosis
ICYMI Multiple Sclerosis
Neurologists need not discourage breastfeeding in women with MS
ICYMI Multiple Sclerosis
Out-of-Pocket Costs for MS Drugs Rose Significantly
ICYMI Multiple Sclerosis
Which Interventions Can Treat Cognitive Fatigue?
ICYMI Multiple Sclerosis
Continuous treatment reduces risk of confirmed disability progression in MS
ICYMI Multiple Sclerosis
Ponesimod reduces annualized relapse rate, compared with teriflunomide
ICYMI Multiple Sclerosis